Home Tech Updates Earth Science Tech, Inc. Shares Updates on its CBD Formula Patents and Medical Device Progress

Earth Science Tech, Inc. Shares Updates on its CBD Formula Patents and Medical Device Progress

by Yolando B. Adams

DORAL, Florida, June 07, 2018 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a revolutionary biotech company focused at the cannabidiol (CBD), nutraceutical, and pharmaceutical fields, scientific devices, as well as research and development, is pleased to share updates on its ongoing CBD formulation patents and scientific device progress.

In March 2018, the Company introduced it had obtained a furnish from the Government of Quebec to increase its three new cannabinoid-based merchandise. The prototyping of the 3 CBD system patents has started at CDBQ. The first batch will be examined by way of the group, and in vitro trying out will start in summer 2019 to expose the superior antioxidant sports and higher anti-proliferative results on breast cancer cells. The stability assessments may be achieved over a 1-yr period. The third product, which is a superfood edible, may be ready for Q4 of 2018. The branding of this particular merchandise is currently inside the planning stage. It is anticipated that those authentic products, made from high first-rate components, will acquire super achievement on the grounds that their function is to hold high-quality of existence, prevent inflammation, most cancers, and degenerative diseases.

Earth Science Tech also stocks its development in the launch of the MSN-2 clinical device and finalization of the ultimate step before huge scale deployment. The enterprise is working with Accélération, Design et Innovation Inc. (ADI Hardware Accelerator). The very last packaging may have a tremendous look that women – the target market – will respect. Our partners from Djibouti, Morocco, Vietnam, and the Middle East can’t wait to look and take a look at our new clinical device, which is dedicated to improving the health of ladies in their international locations and around the arena.

Image result for Earth Science Tech, Inc. Shares Updates on its CBD Formula Patents and Medical Device Progress

The Company’s CEO and Chief Science Officer, Dr. Michel Aubé, said, “The official launch of this clinical tool is a touch like giving delivery. It could be particular in the market, and we are branding this device globally. The commercial name could be introduced quickly, as we are within the system of trademark protection for the logo and name. We will create a robust call for this medical device by using displaying the world its powerful potential to decrease the superiority of chlamydia and other Sexually Transmitted Infections.”

About Earth Science Tech, Inc. (ETST)

Earth Science Tech, Inc. (“EST”) offers the highest purity and high-quality, high-grade complete spectrum cannabinoid oil in the marketplace. There are tremendous results in studies on breast most cancer and immune cells thru the University of Central Oklahoma, and research thru DV Biologics proved it lowers cortisol and features as a neuroprotectant, with nice result case research thru key health companies. ETST formulates, markets, and distributes the CBD oil used for its studies to the general public, imparting the simplest excellent of CBD available on the market.

To learn more, please go to www.EarthScienceTech.Com

ETST presently has three wholly-owned subsidiaries centered on growing its role as an international leader within the CBD area and increasing its work in the pharmaceutical and clinical tool sectors. These subsidiaries include:

Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. Is a wholly-owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharma, Inc. (“ESP”), that’s dedicated to the improvement of low-value, noninvasive diagnostic tools, scientific gadgets, checking out procedures, and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and leader science officer, Dr. Michel Aubé, is leading the organization’s research and improvement efforts. The business enterprise’s first medical tool, MSN-2, is a domestic package designed for the detection of STIs, together with chlamydia, from a self-obtained gynecological specimen. ESP is operating to expand and produce to marketplace clinical devices and vaccines that meet the unique needs of girls.

Cannabis Therapeutics

Cannabis Therapeutics, Inc. Is a wholly-owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics, Inc. (“CTI”), is poised to take a leadership role in the development of new, leading-facet, cannabinoid-primarily based pharmaceutical and nutraceutical products. CTI is invested in studies and development to explore and harness the medicinal strength of cannabidiol. The employer holds three provisional software patents for a CBD product that is focused on growing remedies for breast and ovarian cancers, as well as two typical CBD-based totally pharmaceutical tablets.

Image result for Earth Science Tech, Inc. Shares Updates on its CBD Formula Patents and Medical Device Progress

KannaBidioid, Inc. Is a wholly-owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioiD, Inc. (“KBD”) presents an extensive type of merchandise geared closer to the recreational area of hashish. KBD’s unique Kanna and CBD method is bought and allotted in CBD-infused vapes/e-beverages products. Kanna and CBD synergistically beautify each other, providing the greatest rest, an uplifting sensation, better recognition, and the brought benefit of assisting with nicotine reduction remedies.

Earth Science Foundation, Inc.

Earth Science Foundation, Inc. Is an entirely owned subsidiary of Earth Science Tech, Inc. (ETST). Earth Science Foundation, Inc. (“ESF”) is inside the method of becoming a non-profit agency to just accept grants and donations to conduct further studies and assist donate Earth Science Tech, Inc’s powerful CBD merchandise to the ones in need.
To study extra, please go to www.ETSTFoundtion.Org

SAFE HARBOR ACT: Forward-Looking Statements are included inside the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements concerning our predicted future financial position, outcomes of operations, coins flow, financing plans, commercial enterprise method, products and services, aggressive positions, boom opportunities, plans and targets of control for future operations, along with words together with “expect,” “if,” “accept as true with,” “plan,” “estimate,” “count on,” “intend,” “might also,” “could,” “have to,” “will,” and other similar expressions are forward-searching statements and contain risks, uncertainties, and contingencies, lots of which are past our manipulate, which can also motive real outcomes, overall performance, or achievements to differ materially from predicted effects, overall performance, or achievements. We are below no responsibility to (and expressly disclaim any such obligation to) replace or adjust our ahead-searching statements, whether or not as a result of the latest data, future occasions, or otherwise.

related articles